Protenus Granted New Patent for Drug Diversion Surveillance Technology

By May 24, 2023 August 20th, 2023 News

Protenus, provider of the leading healthcare compliance analytics platform empowering healthcare to eliminate risk, is pleased to announce the grant of a new patent to protect the intellectual property of its drug diversion surveillance technology.

By definition, drug diversion is the use of prescription drugs for something other than their intended medical purpose. Simply put, drug diversion is theft of prescription medications. Protenus Drug Diversion Surveillance utilizes artificial intelligence and advanced analytics to audit 100% of medication use transactions — reducing the risk to a health system’s workforce, organization, and most importantly, its patients.

U.S. Patent No. 11,621,065 was issued on May 22, 2023, titled “Methods and Systems for Analyzing Accessing of Drug Dispensing Systems.” With this patent, Protenus further expands the patent portfolio covering various techniques for detecting anomalous drug dispensing events. For example, the newly-granted patent covers determining a possible misappropriation event, displaying an alert, and allowing a user to provide feedback. The patent further describes modifying the rules or patterns for detecting possible subsequent misappropriation events based on the feedback.

Protenus now holds several granted U.S. patents covering various key aspects of patient privacy monitoring and drug diversion surveillance technologies, along with several other pending U.S. and foreign patent applications.